Reduction of circulating endothelial cells in peripheral blood of ALS patients

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Garbuzova Davis, Svitlana ^a   Woods III , Robert L ^a   Louis, Michael K ^a   Zesiewicz, Theresa A ^a   Kuzmin Nichols, Nicole ^b   Sullivan, Kelly L ^a   Miller, Amber M ^a   Hernandez Ontiveros, Diana G ^a   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Saneron CCEL Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIGENS, CD146; CASE-CONTROL STUDIES; CELL MOVEMENT; DEMOGRAPHY; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

ANIMALIA;

EID: 77956526511     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010614     Document Type: Article

References (54)

1. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
2. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806-819.
3. Strong MJ, Kesavapany S, Pant HC (2005) The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol 64: 649-664.
4. Consilvio C, Vincent AM, Feldman EL (2004) Neuroinflammation, COX-2, and ALS-a dual role? Exp Neurol 187: 1-10.
5. Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27: 723-749.
6. Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7: 710-723.
7. Mitchell JD, Borasio GD (2007) Amyotrophic lateral sclerosis. Lancet 369: 2031-2041.
8. Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, et al. (2007) Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res 1157: 126-137.
9. Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, et al. (2007) Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001205. Accessed 2010 Feb 14.
10. Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, et al. (2008) ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11: 420-422.
11. Rule RR, Schuff N, Miller RG, Weiner MW (2010) Gray matter perfusion correlates with disease severity in ALS. Neurology 74: 821-827.
12. Nicaise C, Soyfoo MS, Authelet M, De Decker R, Bataveljic D, et al. (2009) Aquaporin-4 overexpression in rat ALS model. Anat Rec (Hoboken) 292: 207-213.
13. Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, et al. (2009) Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res 1301: 152-162.
14. Henkel JS, Beers DR, Wen S, Bowser R, Appel SH (2009) Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology 72: 1614-1616.
15. Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, et al. (2005) Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med 11: 959-965.
16. Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118: 103-113.
17. Avata C, Ropper AH (2002) Ischaemic brain oedema. J Clin Neurosci 9: 113-124.
18. Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, et al. (2010) Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol Feb 17. [Epub ahead of print].
19. Kirk J, Plumb J, Mirakhur M, McQuaid S (2003) Tight junctional abnormality in multiple sclerosis white matter affects all calibers of vessel and associated with blood-brain barrier leakage and active demyelination. J Pathol 201: 319-327.
20. Vos CMP, Geurts JJG, Montagne L, van Haastert ES, Bö L, et al. (2005) Bloodbrain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis 20: 953-960.
21. Garbuzova-Davis S, Saporta S, Sanberg PR (2008) Implications of blood-brain barrier disruption in ALS. Amyotroph Lateral Scler 9: 375-376.
22. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, et al. (2005) Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 93: 228-235.
23. Erdbruegger U, Haubitz M, Woywodt A (2006) Circulating endothelial cells: a novel marker of endothelial damage. Clin Chim Acta 373: 17-26.
24. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Eng. J Med 348: 593-600.
25. Chong AY, Lip GY, Freestone B, Blann AD (2006) Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin. Eur J Heart Fail 8: 167-172.
26. Nadar SK, Lip GY, Lee KW, Blann AD (2005) Circulating endothelial cells in acute ischaemic stroke. Thromb Haemost 94: 707-712.
27. Hunting CB, Noort WA, Zwaginga JJ (2005) Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization. Vox Sang 88: 1-9.
28. Dome B, Timar J, Ladanyi A, Paku S, Renyi-Vamos F, et al. (2009) Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy. Crit Rev Oncol Hematol 69: 108-124.
29. Goon PK, Lip GY, Stonelake PS, Blann AD (2009) Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. Neoplasia 11: 771-779.
30. Lee KW, Lip GY, Tayebjee M, Foster W, Blann AD (2005) Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 105: 526-532.
31. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
32. Rafii S (2000) Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 105: 17-19.
33. Woywodt A, Bahlmann FH, De Groot K, Haller H, Haubitz M (2002) Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 17: 1728-1730.
34. McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26: 459-470.
35. Boillée S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59.
36. Cho KJ, Chung YH, Shin C, Shin DH, Kim YS, et al. (1999) Reactive astrocytes express p53 in the spinal cord of transgenic mice expressing a human Cu/Zn SOD mutation. Neuroreport 10: 3939-3943.
37. Henkel JS, Engelhardt JI, Siklós L, Simpson EP, Kim SH, et al. (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55: 221-235.
38. Levine JB, Kong J, Nadler M, Xu Z (1999) Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 28: 215-224.
39. Appel SH, Simpson EP (2001) Activated microglia: the silent executioner in neurodegenerative disease? Curr Neurol Neurosci Rep 1: 303-305.
40. Engelhardt JI, Tajt J, Appel SH (1993) Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 50: 30-36.
41. Alexianu ME, Kozovska M, Appel SH (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57: 1282-1289.
42. Hensley K, Floyd RA, Gordon B, Mou S, Pye QN, et al. (2002) Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 82: 365-374.
43. Almer G, Guégan C, Teismann P, Naini A, Rosoklija G, et al. (2001) Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 49: 176-185.
44. Graves MC, Fiala M, Dinglasan LA, Liu NQ, Sayre J, et al. (2004) Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord 5: 213-219.
45. Elliott JL (2001) Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 95: 172-178.
46. Almer G, Vukosavi C S, Romero N, Przedborski S (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 72: 2415-2425.
47. Engelhardt JI, Soós J, Obál I., Vigh L., Siklos L. (2005) Subcellular localization of IgG from sera of ALS patients in the nervous system. Acta Neurol Scand 112: 126-133.
48. Chow N, Bell RD, Deane R, Streb JW, Chen J, et al. (2007) Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc Natl Acad Sci U S A 104: 823-828.
49. Bell RD, Deane R, Chow N, Long X, Sagare A, et al. (2009) SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 11: 143-153.
50. Delorme B, Basire A, Gentile C, Sabatier F, Monsonis F, et al. (2005) Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 94: 1270-1279.
51. Zhong Z, Ilieva H, Hallagan L, Bell R, Singh I, et al. (2009) Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J Clin Invest 119: 3437-3449.
52. Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ''Clinical limits of amyotrophic lateral sclerosis'' workshop contributors. J Neurol Sci 124: Suppl 96-107.
53. Brooks BR, Miller RG, Swash M, Munsa TL (2000) World Federation of neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293-299.
54. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, et al. (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169: 13-21.